Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2021

Apr 7, 2021

29841_dirs_2021-04-07_b0374c1f-9f84-45eb-9abc-ab4047785d3b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-04-05

Reporting Person: Martha Geoffrey (Director, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-05 Ordinary Shares M 2404 $41.60 Acquired 84342 Direct
2021-04-05 Ordinary Shares S 2404 $118.83 Disposed 81938 Direct
2021-04-05 Ordinary Shares M 9308 $55.32 Acquired 91246 Direct
2021-04-05 Ordinary Shares S 9308 $118.83 Disposed 81938 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-05 Stock Option (Right to Buy) $41.60 M 2404 Disposed 2022-10-29 Ordinary Shares (2404) Direct
2021-04-05 Stock Option (Right to Buy) $55.32 M 9308 Disposed 2023-07-29 Ordinary Shares (9308) Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This balance increased by 844 shares due to exempt transactions such as dividend reinvestment.

F3: This option to purchase 2,404 Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 2,404 Medtronic Inc. common stock shares for $41.60 per share.
This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.

F4: This option to purchase 1,808 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,808 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.

F5: This option to purchase 20,481 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 20,481 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.